Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Toyohara, J.; Al-Qahtani, M.; Huang, Yy; Cazzola, E.; Todde, S.; Furumoto, S.; Mikolajczak, R.; Decristoforo, C.; Gillings, N.; Yang, M.; Reilly, R.; Duatti, A.; Denkova, A.; Schirrmacher, R.; Carlucci, G.; Seimbille, Y.; Liu, Z.; Ellis, B.; Cornelissen, Bt; Kopka, Klaus; Bernardes, E.

doi:10.1186/s41181-022-00177-w

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Toyohara, J.; Al-Qahtani, M.; Huang, Y.; Cazzola, E.; Todde, S.; Furumoto, S.; Mikolajczak, R.; Decristoforo, C.; Gillings, N.; Yang, M.; Reilly, R.; Duatti, A.; Denkova, A.; Schirrmacher, R.; Carlucci, G.; Seimbille, Y.; Liu, Z.; Ellis, B.; Cornelissen, B.; Kopka, K.; Bernardes, E.

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development.
Main body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals.
Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

Keywords: Highlight Articles; Nuclear Medicine; Radiochemistry; Radiopharmaceutical Sciences; Radiopharmacy; Trends in Radiopharmaceutical Sciences

EJNMMI Radiopharmacy and Chemistry 7(2022)1, 25
DOI: 10.1186/s41181-022-00177-w

Permalink: https://www.hzdr.de/publications/Publ-35288